Home
Orbimed Advisors reported a 2.6% stake in ADC Therapeutics ADCT · 3,230,797 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.6%
- Last report
- 3.6% · filed 25/02/14
- Shares held
- 3,230,797 sh
- Class
- Common Shares, par value CHF 0.08 per share
- Holder
- Orbimed Advisors
- Event date
- 25/12/31
- Filed
- 26/02/17
2.6% stake · below 5%
- Stake
- 2.6%
- Last report
- 3.6%
- Since last report
- −1.0pp
ADC Therapeutics trades, last 26 weeks
What else happened in ADC Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
